Response of the primary tumor in symptomatic and asymptomatic stage IV colorectal cancer to combined interventional endoscopy and palliative chemotherapy

BMC Cancer

Volumn 9, Issue , 2009, Pages

  Cameron, Silke ^a   Hünerbein, Diana ^a   Mansuroglu, Tümen ^a   Armbrust, Thomas ^a   Scharf, Jens Gerd ^a   Schwörer, Harald ^a   Füzesi, László ^a   Ramadori, Giuliano ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BEVACIZUMAB; CAPECITABINE; CETUXIMAB; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

ADULT; AGE DISTRIBUTION; AGED; ANEMIA; ARTICLE; BLEEDING DISORDER; CANCER PALLIATIVE THERAPY; CANCER RELAPSE; CANCER STAGING; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DEATH; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; ENDOSCOPIC THERAPY; FATIGUE; FEMALE; HAND FOOT SYNDROME; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFECTION; INOPERABLE CANCER; INTESTINE PERFORATION; LEUKOPENIA; MALE; METASTASIS; NIGHT SWEAT; OBSTRUCTION; POLYNEUROPATHY; PRIMARY TUMOR; SEX DIFFERENCE; SIDE EFFECT; SURVIVAL TIME; SYMPTOMATOLOGY; THROMBOEMBOLISM; TREATMENT RESPONSE; TUMOR REGRESSION; WEIGHT REDUCTION; COLORECTAL TUMOR; DISEASE COURSE; ENDOSCOPY; METHODOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PALLIATIVE THERAPY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; ENDOSCOPY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PALLIATIVE CARE; TREATMENT OUTCOME;

EID: 67651062354     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-218     Document Type: Article

References (34)

1. Martin ES Tonon G Sinha R Xiao Y Feng B Kimmelman AC Protopopov A Ivanova E Brennan C Montgomery K et al Common and distinct genomic events in sporadic colorectal cancer and diverse cancer types Cancer Res 2007, 67(22):10736-10743. 10.1158/0008-5472.CAN-07-2742 18006816
2. Benoist S Pautrat K Mitry E Rougier P Penna C Nordlinger B Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastases Br J Surg 2005, 92(9):1155-1160. 10.1002/ bjs.5060 16035135
3. Muratore A Zorzi D Bouzari H Amisano M Massucco P Sperti E Capussotti L Asymptomatic colorectal cancer with un-resectable liver metastases: immediate colorectal resection or up-front systemic chemotherapy? Ann Surg Oncol 2007, 14(2):766-770. 10.1245/s10434-006-9146-1 17103261
4. Simmonds PC Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. Colorectal Cancer Collaborative Group BMJ 2000, 321(7260):531-535. 27466 10968812 10.1136/ bmj.321.7260.531
5. Omura K Advances in chemotherapy against advanced or metastatic colorectal cancer Digestion 2008, 77(Suppl 1):13-22. 10.1159/000111483 18204257
6. Gruenberger B Scheithauer W Punzengruber R Zielinski C Tamandl D Gruenberger T Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases BMC Cancer 2008, 8:120-127. 2386791 18439246 10.1186/1471-2407-8-120
7. Folprecht G Seymour MT Saltz L Douillard JY Hecker H Stephens RJ Maughan TS Van Cutsem E Rougier P Mitry E et al Irinotecan/fluorouracil combination in first-line therapy of older and younger patients with metastatic colorectal cancer: Combined analysis of 2,691 patients in randomized controlled trials J Clin Oncol 2008, 26(9):1443-1451. 10.1200/ JCO.2007.14.0509 18349394
8. Emmanouilides C Sfakiotaki G Androulakis N Kalbakis K Christophylakis C Kalykaki A Vamvakas L Kotsakis A Agelaki S Diamandidou E et al Front-line bevacizumab in combination with oxaliplatin, leucovorin and 5-fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: A multicenter phase II study BMC Cancer 2007, 7:91. 1894803 17537235 10.1186/1471-2407-7-91
9. Zampino MG Magni E Massacesi C Zaniboni A Martignetti A Zorzino L Lorizzo K Santoro L Boselli S de Braud F First clinical experience of orally active epidermal growth factor receptor inhibitor combined with simplified FOLFOX6 as first-line treatment for metastatic colorectal cancer Cancer 2007, 110(4):752-758. 10.1002/cncr.22851 17594712
10. Field K Lipton L et al Metastatic colorectal cancer-past, progress and future World J Gastroenterol 2007, 13(28):3806-3815. 17657834
11. Becouarn Y Senesse P Thezenas S Boucher E Adenis A Cany L Jacob JH Cvitkovic F Montoto-Grillot C Ychou M A randomized phase II trial evaluating safety and efficacy of an experimental chemotherapy regimen (irinotecan + oxaliplatin, IRINOX) and two standard arms (LV5 FU2 + irinotecan or LV5 FU2 + oxaliplatin) in first-line metastatic colorectal cancer: A study of the Digestive Group of the Federation Nationale des Centres de Lutte Contre le Cancer Ann Oncol 2007, 18(12):2000-2005. 10.1093/annonc/mdm379 17785765
12. Tabernero J Van Cutsem E Diaz-Rubio E Cervantes A Humblet Y Andre T Van Laethem JL Soulie P Casado E Verslype C et al Phase II trial of cetuximab in combination with fluorouracil, leucovorin, and oxaliplatin in the first-line treatment of metastatic colorectal cancer J Clin Oncol 2007, 25(33):5225-5232. 10.1200/JCO.2007.13.2183 18024868
13. Stelzner S Hellmich G Koch R Ludwig K et al Factors predicting survival in stage IV colorectal carcinoma patients after palliative treatment: A multivariate analysis J Surg Oncol 2005, 89(4):211-217. 10.1002/ jso.20196 15726622
14. Puthillath A Dunn KB Rajput A Smith J Yang G Wilding GE Tan W Gupta B Fakih MG et al Safety and efficacy of first-line chemotherapy in unresected metastatic colorectal cancer Clin Colorectal Cancer 2007, 6(10):710-715. 10.3816/CCC.2007.n.040 18039424
15. O'Neill BD Brown G Heald R Cunnigham D Tait DM Non-operative treatment after neoadjuvant chemoradiotherapy for rectal cancer Lancet Oncology 2007, 8:625-633. 10.1016/S1470-2045(07)70202-4 17613424
16. Longo WE Ballantyne GH Bilchik AJ Modlin IM Advanced rectal cancer. What is the best palliation? Dis Colon Rectum 1988, 31(11):842-847. 10.1007/ BF02554846 2460299
17. Rosen SA Buell JF Yoshida A Kazsuba S Hurst R Michelassi F Millis JM Posner MC Initial presentation with stage IV colorectal cancer: How aggressive should we be? Arch Surg 2000, 135(5):530-534. discussion 534-535 10.1001/archsurg.135.5.530 10807276
18. Ruo L Gougoutas C Paty PB Guillem JG Cohen AM Wong WD Elective bowel resection for incurable stage IV colorectal cancer: Prognostic variables for asymptomatic patients J Am Coll Surg 2003, 196(5):722-728. 10.1016/ S1072-7515(03)00136-4 12742204
19. Sarela AI Guthrie JA Seymour MT Ride E Guillou PJ O'Riordain DS Non-operative management of the primary tumour in patients with incurable stage IV colorectal cancer Br J Surg 2001, 88(10):1352-1356. 10.1046/j.0007-1323.2001.01915.x 11578291
20. Mella J Biffin A Radcliffe AG Stamatakis JD Steele RJ Population-based audit of colorectal cancer management in two UK health regions. Colorectal Cancer Working Group, Royal College of Surgeons of England Clinical Epidemiology and Audit Unit Br J Surg 1997, 84(12):1731-1736. 10.1002/bjs.1800841224 9448628
21. Scoggins CR Meszoely IM Blanke CD Beauchamp RD Leach SD Nonoperative management of primary colorectal cancer in patients with stage IV disease Ann Surg Oncol 1999, 6(7):651-657. 10.1007/s10434-999-0651-x 10560850
22. Padhani AR Ollivier L The RECIST (Response Evaluation Criteria in Solid Tumors) criteria: Implications for diagnostic radiologists Br J Radiol 2001, 74(887):983-986. 11709461
23. Panageas KS Ben-Porat L Dickler MN Chapman PB Schrag D When you look matters: The effect of assessment schedule on progression-free survival J Natl Cancer Inst 2007, 99(6):428-432. 10.1093/jnci/djk091 17374832
24. Guthrie JA Colorectal cancer: Follow-up and detection of recurrence Abdom Imaging 2002, 27(5):570-577. 10.1007/s00261-001-0081-0 12173001
25. Baumhoer D Armbrust T Ramadori G et al Nonsurgical treatment of the primary tumor in four consecutive cases of metastasized colorectal carcinoma Endoscopy 2005, 37(12):1232-1236. 10.1055/s-2005-870225 16329023
26. Armbrust T Sobotta M Fuzesi L Grabbe E Ramadori G Chemotherapy-induced suppression to adenoma or complete suppression of the primary in patients with stage IV colorectal cancer: Report of four cases Eur J Gastroenterol Hepatol 2007, 19(11):988-994. 10.1097/MEG.0b013e3282efa41f 18049169
27. Ramadori G Lindhorst A Armbrust T Colorectal tumors with complete obstruction - endoscopic recovery of passage replacing emergency surgery? A report of two cases BMC Gastroenterol 2007, 7:14. 1847445 17391506 10.1186/1471-230X-7-14
28. Schmiegel W Pox C Reinacher-Schick A Adler G Fleig W Fölsch UR Frühmorgen P Hohenberger W Holstege A et al S3-Leitlinie "Kolorektales Karzinom", Ergebnisse evidenzbasierter Konsensuskonferenzen am 6./7. Februar 2004 und am 8./9. Juni 2007 (für die Themenkomplexe IV, VI, VII) - S3-Guideline "Colorectal Cancer" 2004/2008 Z Gastroenterol 2008, 46:799-840. 10.1055/s-2008-1027726 18759205
29. Engstrom PF Benson AB Chen YJ Choti MA Dilawari RA Enke CA Fakih MG Fuchs C Kiel K Knol JA et al Colon cancer clinical practice guidelines in oncology J Natl Compr Canc Netw 2005, 3(4):468-491. 16038639
30. Barnert J Messmann H et al Management of lower gastrointestinal tract bleeding Best Pract Res Clin Gastroenterol 2008, 22(2):295-312. 10.1016/ j.bpg.2007.10.024 18346685
31. Mentha G Majno PE Andres A Rubbia-Brandt L Morel P Roth AD Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary Br J Surg 2006, 93(7):872-878. 10.1002/bjs.5346 16671066
32. Temple LKF Hsieh L Wong WD Saltz L Schrag D Use of Surgery Among Elderly Patients With Stage IV Colorectal Cancer J Clin Oncol 2004, 22:3475-3484. 10.1200/JCO.2004.10.218 15337795
33. Folprecht G Grothey A Alberts S Raab HR Kohne CH Neoadjuvant treatment of unresectable colorectal liver metastases: Correlation between tumour response and resection rates Ann Oncol 2005, 16(8):1311-1319. 10.1093/ annonc/mdi246 15870084
34. Chau I Brown G Cunningham D Tait D Wotherspoon A Norman AR Tebbutt N Hill M Ross PJ Massey A et al Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer J Clin Oncol 2006, 24:668-674. 10.1200/JCO.2005.04.4875 16446339